Principles of Disease Surveillance
Pharmacovigilance
Survey Safety
Censoring Survival Data
Assumptions of Survival Analysis
Difference from Background: Limit of Detection
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Andrew Bate1, Elliot G Brown, Stephen A Goldman
1Pfizer, Inc., New York, NY 10017, USA. andrew.bate@pfizer.com
No abstract available in PubMed .